Skip to main content
OpenTrials

Clinical trial condition

Non-Muscle Invasive Bladder Neoplasms

Explore clinical trials studying Non-Muscle Invasive Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

195 public trials 69 recruiting studies
Refine in advanced search Browse all conditions

Non-Muscle Invasive Bladder Neoplasms trial results

Completed

The Bladder Instillation Comparison Study

NCT02695771

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • Spectrum Health Medical Group-Division of Urology-LHCP Grand Rapids, Michigan, United States
  • Spectrum Health Medical Group-Division of Urology Grand Rapids, Michigan, United States
  • Urologic Consultants P.C. Grand Rapids, Michigan, United States
View Trial Details
Completed

VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer

NCT02371447

Conditions
Bladder Cancer, Carcinoma, Female Urogenital Diseases, +13 more
Locations
  • Universitätsklinikum Freiburg Freiburg im Breisgau, Germany
  • Universitätsklinikum der Ruhr-Universität Bochum Herne, Germany
  • Universitätsklinikum Jena Jena, Germany
  • Universitätsmedizin der Johannes Gutenberg Universität Mainz Mainz, Germany
View all 16 locations
View Trial Details
Completed

A Phase 1 Study of Intravesical VAX014 for Instillation in Subjects With Non-Muscle Invasive Bladder Cancer

NCT03854721

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • The Urology Center of Colorado Denver, Colorado, United States
  • University of Iowa Hospital and Clinics Iowa City, Iowa, United States
  • New Jersey Urology, LLC. Edison, New Jersey, United States
  • Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
View Trial Details
Completed

A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X)

NCT03664258

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • University Clinic for Urology and Andrology Salzburg, Austria
  • Medical University of Vienna Vienna, Austria
  • Teaching Hospital Motol Prague, Czechia
  • CHU Toulouse / Institut Universitaire du Cancer Toulouse Oncopole Toulouse, France
View all 13 locations
View Trial Details
Completed

A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer

NCT03558503

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
Locations
  • Mayo Clinic Cancer Center Phoenix, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • Loma Linda University Loma Linda, California, United States
  • Providence Medical Institute Santa Monica, California, United States
View all 19 locations
View Trial Details

Related conditions